Status:

UNKNOWN

Single Ascending Dose Study in Participants With LCA10

Lead Sponsor:

Editas Medicine, Inc.

Conditions:

Leber Congenital Amaurosis 10

Inherited Retinal Dystrophies

Eligibility:

All Genders

3+ years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to evaluate the safety, tolerability and efficacy of a single escalating doses of EDIT-101 administered via subretinal injection in participants with LCA10 caused by a hom...

Detailed Description

This is an open-label, single ascending dose study of EDIT-101 in adult and pediatric (ie, ages 3 to 17) participants with LCA10-IVS26. Up to 34 participants will be enrolled in up to 5 cohorts to eva...

Eligibility Criteria

Inclusion

  • Male or female
  • At least 3 years of age at screening with CEP290-related retinal degeneration caused by a homozygous or compound heterozygous mutation involving c.2991+1655A\>G in IVS26 of the CEP290 gene.
  • Visual Acuity:
  • Sentinel participant will have severe vision loss with a logMAR BCVA of ≥1.6 to 3.9 (20/800 or worse to LP) in the study eye
  • Non-sentinel participants must have BCVA between 1.0 - 3.0 logMAR in the study eye

Exclusion

  • Other known disease-causing mutations
  • Achieves a passing score for the mobility course at the most difficult level
  • In either eye, active systemic or ocular/intraocular infection or inflammation
  • In either eye, history of steroid-responsive intraocular pressure with increases \> 25 mm Hg following corticosteroid exposure
  • Any vaccination/immunization in the last 28 days before screening
  • Inability or unwillingness to take oral prednisone
  • Prior gene therapy or oligonucleotide treatment

Key Trial Info

Start Date :

September 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 23 2025

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT03872479

Start Date

September 26 2019

End Date

May 23 2025

Last Update

December 5 2022

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Bascom Palmer Eye Institute

Miami, Florida, United States, 33136

2

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, United States, 02114

3

W.K. Kellogg Eye Center - University of Michigan

Ann Arbor, Michigan, United States, 48105

4

Casey Eye Institute - OSHU

Portland, Oregon, United States, 97239